Sep 8, 2026 04:05PM
Aug 19, 2026 04:05PM
Aug 19, 2026 04:05PM
Aug 12, 2026 04:01PM
Aug 5, 2026 08:30AM
May 19, 2026 04:45PM
May 13, 2026 04:01PM Journey Medical Corporation Reports First Quarter 2026 Financial Results and Recent Corporate Highlights
May 6, 2026 04:01PM
Apr 21, 2026 08:30AM
Apr 21, 2026 08:30AM
Mar 25, 2026 04:01PM
Mar 18, 2026 08:30AM
Dec 10, 2025 08:30AM
Dec 10, 2025 08:30AM Journey Medical Corporation Announces Publication of Clinical Trial Results Assessing the Impact of Emrosi™ (DFD-29) on Microbial Flora of Healthy Adults in the Journal of Drugs in Dermatology
Nov 12, 2025 04:01PM
Nov 5, 2025 08:30AM
Oct 24, 2025 08:30AM
Oct 24, 2025 08:30AM
Oct 8, 2025 08:30AM
Sep 3, 2025 08:30AM
Aug 18, 2025 08:30AM Journey Medical Corporation to Present at the Emerging Growth Conference
Aug 12, 2025 04:01PM
Aug 7, 2025 08:30AM
Aug 7, 2025 08:30AM
Aug 5, 2025 04:01PM
Jul 14, 2025 08:31AM
Jul 14, 2025 08:30AM
Jun 24, 2025 08:31AM Journey Medical Corp (DERM) set to join Russell 2000 and 3000
Jun 24, 2025 08:30AM
Jun 20, 2025 08:32AM
Jun 20, 2025 08:30AM
Jun 9, 2025 08:30AM
May 15, 2025 04:05PM
May 14, 2025 04:01PM
May 7, 2025 04:01PM Journey Medical Corporation to Announce First Quarter 2025 Financial Results on May 14, 2025
Apr 1, 2025 04:01PM
Apr 1, 2025 04:01PM
Mar 26, 2025 04:01PM
Mar 24, 2025 08:30AM
Mar 19, 2025 04:01PM
Mar 12, 2025 08:30AM
Mar 5, 2025 04:01PM Journey Medical Corp (DERM) Announces Publication of the Phase 3 Clinical Trial Results of Emrosi
Mar 5, 2025 04:01PM
Mar 4, 2025 04:01PM
Jan 23, 2025 08:30AM
Nov 14, 2024 04:10PM
Nov 12, 2024 04:01PM
Nov 4, 2024 07:01AM
Nov 4, 2024 07:00AM Journey Medical Corporation Announces U.S. FDA Approval of Emrosi™ (Minocycline Hydrochloride Extended Release Capsules, 40 mg) for the Treatment of Rosacea
Oct 25, 2024 08:30AM

332,104 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All